Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth- stimulating

Cancer Immunology Immunotherapy

Volumn 48, Issue 11, 2000, Pages 603-612

  Chen, Rong Long ^a   Reynolds, C Patrick ^a,b   Seeger, Robert C ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

ADCC; Calcein AM; Digital image microscopy; Fluorescein diacetate; GD2; Neuroblastoma; Neutrophils

Indexed keywords

CALCEIN; FLUORESCEIN DIACETATE; GANGLIOSIDE GD2; MONOCLONAL ANTIBODY;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CANCER INHIBITION; CELL COUNT; CYTOTOXICITY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NEUROBLASTOMA CELL; NEUTROPHIL; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0033956432     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050008     Document Type: Article

References (35)

1. 1. Baldwin GC, Chung GY, Kaslander C, Esmail T, Reisfeld RA, Golde DW (1993) Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells. Br J Haematol 83:545
2. 2. Barker E, Mueller BM, Handgretinger R, Herter M, Yu AL, Reisfeld RA (1991) Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells. Cancer Res 51:144
3. 3. Broxterman HJ, Sonneveld P, Feller N, Ossenkoppele GJ, Wahrer DC, Eekman CA, Schoester M, Lankelma J, Pinedo HM, Lowenberg B, Schuurhuis GJ (1996) Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity. Blood 87:4809
4. 4. Cheung NK, Lazarus H, Miraldi FD, Abramowsky CR, Kallick S, Saarinen UM, Spitzer T, Strandjord SE, Coccia PF, Berger NA (1987) Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. J Clin Oncol 5:1430
5. 5. Dillman RO (1994) Antibodies as cytotoxic therapy. J Clin Oncol 12:1497
6. 6. Essodaigui M, Broxterman HJ, Garnier-Suillerot A (1998) Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry 37:2243
7. 7. Feller N, Kuiper CM, Lankelma J, Ruhdal JK, Scheper RJ, Pinedo HM, Broxterman HJ (1995) Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry. Br J Cancer 72:543
8. 8. Frost JD, Hank JA, Reaman GH, Frierdich S, Seeger RC, Gan J, Anderson PM, Ettinger LJ, Cairo MS, Blazar BR, Krailo MD, Matthay KK, Reisfeld RA, Sondel PM (1997) A phase I/ IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer 80:317
9. 9. Hahn T, Or R, Bruchelt G, Malach L, Karov Y, Lefshitz Mercer B, Evron R, Barak Y (1996) Control of neuroblastoma cell proliferation and differentiation by human bone marrow. Cancer 77:2614
10. 10. Handgretinger R, Anderson K, Lang P, Dopfer R, Klingebiel T, Schrappe M, Reuland P, Gillies SD, Reisfeld RA, Neithammer D (1995) A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. Eur J Cancer 31A:261
11. 11. Hank JA, Surfus J, Gan J, Chew TL, Hong R, Tans K, Reisfeld R, Seeger RC, Reynolds CP, Bauer M, et al (1994) Treatment of neuroblastoma patients with antiganglioside GD2 antibody plus interleukin-2 induces antibody-dependent cellular cytotoxicity against neuroblastoma detected in vitro. J Immunother 15:29
12. 12. Hofstra TC, Kalra VK, Meiselman HJ, Coates TD (1996) Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst. Blood 87:4440
13. 13. Hollo Z, Homolya L, Davis CW, Sarkadi B (1994) Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim Biophys Acta 1191:384
14. 14. Jonsson B, Liminga G, Csoka K, Fridborg H, Dhar S, Nygren P, Larsson R (1996) Cytotoxic activity of calcein acetoxymethyl ester (calcein/AM) on primary cultures of human haematological and solid tumours. Eur J Cancer 32A:883
15. 15. Keshelava N, Seeger RC, Groshen S, Reynolds CP (1998) Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy. Cancer Res 58:5396
16. 16. Kushner BH, Cheung NK (1991) Clinically effective monoclonal antibody 3F8 mediates nonoxidative lysis of human neuroectodermal tumor cells by polymorphonuclear leukocytes. Cancer Res 51:4865
17. 17. Kushner BH, Cheung NK (1992) Absolute requirement of CD11/CD18 adhesion molecules, FcRII and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity. Blood 79:1484
18. 18. Lichtenfels R, Biddison WE, Schulz H, Vogt AB, Martin R (1994) CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods 172:227
19. 19. Liminga G, Nygren P, Dhar S, Nilsson K, Larsson R (1995) Cytotoxic effect of calcein acetoxymethyl ester on human tumor cell lines: drug delivery by intracellular trapping. Anticancer Drugs 6:578
20. 20. Mayer P, Handgretinger R, Bruchelt G, Schaber B, Rassner G, Fierlbeck G (1994) Activation of cellular cytotoxicity and complement-mediated lysis of melanoma and neuroblastoma cells in vitro by murine antiganglioside antibodies MB 3.6 and 14.G2a. Melanoma Res 4:101
21. 21. Ozkaynak MF, Krailo M, Sondel PM, Matthay KK, Reaman GH, Seeger RC (1998) Phase I study of chimeric human/ murine anti-GD2 monocloncal antibody (ch14.18) with GM-CSF in children with neuroblastoma immediately post hematopoietic stem cell transplantation (HSCT): a Children's Cancer Group study. Proc Am Soc Clin Oncol 17:532
22. 22. Pancook JD, Becker JC, Gillies SD, Reisfeld RA (1996) Eradication of established hepatic human neuroblastoma metastases in mice with severe combined immunodeficiency by antibody-targeted interleukin-2. Cancer Immunol Immunother 42:88
23. 23. Pekarek LA, Starr BA, Toledano AY, Schreiber H (1995) Inhibition of tumor growth by elimination of granulocytes. J Exp Med 181:435
24. 24. Proffitt RT, Tran JV, Reynolds CP (1996) A fluorescence digital image microscopy system for quantifying relative cell numbers in tissue culture plates. Cytometry 24:204
25. 25. Reisfeld RA, Mueller BM, Handgretinger R, Yu AL, Gillies SD (1994) Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotherapy. Prog Brain Res 101:201
26. 26. Reynolds CP, Biedler JL, Spengler BA (1986) Characterization of human neuroblastoma cell lines established before and after therapy. J Natl Cancer Inst 76:375
27. 27. Sabzevari H, Gillies SD, Mueller BM, Pancook JD, Reisfeld RA (1994) A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice. Proc Natl Acad Sci USA 91:9626
28. 28. Seeger RC, Rayner SA, Banerjee A, Chung H, Laug WE, Neustein HB, Benedict WE (1977) Morphology, growth chromosomal pattern, and fibrinolytic activity of two new human neuroblastoma cell lines. Cancer Res 37:1364
29. 29. Tiberghien F, Loor F (1996) Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay. Anticancer Drugs 7:568
30. 30. Wada RK, Seeger RC, Brodeur GM, Einhorn PA, Rayner SA, Tomayko MM, Reynolds CP (1993) Human neuroblastoma cell lines that express N-myc without gene amplification. Cancer 72:3346
31. 31. Wang XM, Terasaki PI, Rankin GW, Chia D, Zhong HP, Hardy S (1993) A new microcellular cytotoxicity test based on calcein AM release. Hum Immunol 37:264
32. 32. Whiteside TL, Rinaldo CR, Jr, Herberman RB (1992) Cytolytic cell functions. In: Rose NR, deMacario EC, Fahey JL, Friedman H, Penn GM (eds) Manual of clinical laboratory immunology, 4th edn. American Society of Microbiology, Washington, D.C. p 220
33. 33. Wierda WG, Mehr DS, Kim YB (1989) Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay. J Immunol Methods 122:15
34. 34. Wigler PW (1999) PSC833, cyclosporin A, and dexniguldipine effects on cellular calcein retention and inhibition of the multidrug resistance pump in human leukemic lymphoblasts. Biochem Biophys Res Commun 257:410
35. 35. Yu AL, Uttenreuther-Fischer MM, Huang CS, Tsui CC, Gillies SD, Reisfeld RA, Kung FH (1998) Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma. J Clin Oncol 16:2169